OSIC is an effort between academia, industry & patient advocacy to enable rapid advances against IPF and other ILDs using machine learning. Global, 501(c)(3) CATALYZE THE DISCOVERY OF WIDELY USABLE DIAGNOSTIC CRITERIA BY DEFINING DIGITAL IMAGING BIOMARKERS FOR IDIOPATHIC PULMONARY FIBROSIS AND FIBROTIC INTERSTITIAL LUNG DISEASES, WHICH ARE CURRENTLY EXTREMELY DIFFICULT TO DIAGNOSE AND TREAT BEFORE PERMANENT, AND OFTEN FATAL, DISEASE PROGRESSION HAS OCCURED.